Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
Status:
COMPLETED
Trial end date:
2024-05-19
Target enrollment:
Participant gender:
Summary
To assess the effects of a single IV bolus of HSK3486 single dose on cardiac repolarization (QTc interval of the electrocardiogram, and to evaluate the safety and tolerability of a single IV bolus of HSK3486 in healthy subjects